The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF
about
Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteinsThe MADS box transcription factor MEF2C regulates melanocyte development and is a direct transcriptional target and partner of SOX10MEF2-dependent recruitment of the HAND1 transcription factor results in synergistic activation of target promotersErk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defectsGATA-dependent recruitment of MEF2 proteins to target promotersHRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivomef2ca is required in cranial neural crest to effect Endothelin1 signaling in zebrafishCapturing structure and function in an embryonic heart with biophotonic tools.Connecting teratogen-induced congenital heart defects to neural crest cells and their effect on cardiac functionPathogenesis and new candidate treatments for infantile spasms and early life epileptic encephalopathies: A view from preclinical studiesDifferential binding of an SRF/NK-2/MEF2 transcription factor complex in normal versus neoplastic smooth muscle tissuesDermo-1, a multifunctional basic helix-loop-helix protein, represses MyoD transactivation via the HLH domain, MEF2 interaction, and chromatin deacetylationMyocyte enhancer factor 2c, an osteoblast transcription factor identified by dimethyl sulfoxide (DMSO)-enhanced mineralizationMekk3 is essential for early embryonic cardiovascular developmentA mutant receptor tyrosine phosphatase, CD148, causes defects in vascular developmentMef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasisA p38 MAPK-MEF2C pathway regulates B-cell proliferationEssential role for p38alpha mitogen-activated protein kinase in placental angiogenesisPP2A regulatory subunit Bα controls endothelial contractility and vessel lumen integrity via regulation of HDAC7.Gene profiling techniques and their application in angiogenesis and vascular development.MEF2C silencing attenuates load-induced left ventricular hypertrophy by modulating mTOR/S6K pathway in miceGenome-wide discovery of human heart enhancers.Galpha13 regulates MEF2-dependent gene transcription in endothelial cells: role in angiogenesis.VEGF promotes the transcription of the human PRL-3 gene in HUVEC through transcription factor MEF2CIntegration of flow-dependent endothelial phenotypes by Kruppel-like factor 2Histone deacetylase 5 interacts with Krüppel-like factor 2 and inhibits its transcriptional activity in endothelium.A novel in vitro model for studying quiescence and activation of primary isolated human myoblasts.MEK5 is activated by shear stress, activates ERK5 and induces KLF4 to modulate TNF responses in human dermal microvascular endothelial cellsCardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity.Myocyte enhancer factor 2C function in skeletal muscle is required for normal growth and glucose metabolism in mice.The transcription factor MEF2C negatively controls angiogenic sprouting of endothelial cells depending on oxygenDistinct signaling properties of mitogen-activated protein kinase kinases 4 (MKK4) and 7 (MKK7) in embryonic stem cell (ESC) differentiation.Re-employment of developmental transcription factors in adult heart diseaseTranscription factor MEF2C suppresses endothelial cell inflammation via regulation of NF-κB and KLF2Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells.Tbx1 is a negative modulator of Mef2c.Patterns of gene expression in the sheep heart during the perinatal period revealed by transcriptomic modeling.MEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathyMyocyte enhancer factor 2 and chorion factor 2 collaborate in activation of the myogenic program in DrosophilaTranscriptional pathways in second heart field development.
P2860
Q24290752-A8F70D1D-24B5-4183-98BA-7062026EAA29Q24304297-00F0015F-0F36-4485-A30A-47DCA9BE71A2Q24309833-10B04BD9-31E8-4159-951C-990E4D8AEB44Q24534817-78AE0D19-732B-43E2-8301-42B27E1315A4Q24599616-3A742920-C52C-41FD-A0C6-3DC30AA4F25FQ24623607-6C6035AA-DD89-4D3D-904E-F258B3E7C1CEQ24670788-836620DE-37E0-47B1-A59A-39724CBBB5E5Q26849750-D2CBCE15-4227-409F-A776-735A1D708C3AQ27015114-29E23F0C-9DD4-4ED6-910A-C7B432B07BDAQ27308052-D66386AE-DCC8-4738-A9DF-CC10F7AF0D5DQ28206982-19AF6B0A-C475-427D-84C7-3343A44D477FQ28216516-A0D30373-D955-4323-B451-3D230B421A49Q28507390-AA4B81B4-E860-4300-BD25-9814A3D06C51Q28507667-7BF6955E-F92F-4D78-8279-FB86848DA4A8Q28508534-0FFE19F0-9B32-4AF0-B941-75C1435386FFQ28585695-AB6143B5-E71B-47C0-94B7-B140AECC806CQ28588781-DFE220C5-E1BF-40B9-B09F-0098A666BCC0Q28594675-0B7C83FA-49E4-4397-A86B-1852E48AA55FQ30544640-529B49AA-84E6-40FE-AB9D-C561C1554EB8Q30724640-2A2628A3-854B-45A8-AFC1-01E8EFF2CBB4Q33521236-2FBA6094-5210-4C4D-9FD9-F3B181F2824FQ33523952-7E393C85-D010-4086-B148-14A423251888Q33791835-61329934-0897-4775-BBF2-AB311D8CCD9DQ34071838-54FA46C4-1BA8-442F-A8FF-275767DD279DQ34195975-830F65D1-02DE-4B0E-B942-D8E7738D0B46Q34736483-E17B0D81-0832-4302-AB84-1EEC6A265A35Q34745089-E7D7F5C1-DD8C-4386-8829-844DD4DA2BBCQ34787891-DA17A3AD-E341-4833-BEB3-8BDFBD45CCAFQ35035923-68B23B0D-FBF1-403A-95BB-30F6FB8ABE64Q35190729-25E83717-CB12-48D0-979C-584243F44634Q35200237-BCEBD89E-8489-4AAF-995F-769D23E7E9B7Q35710106-C644C40E-669F-4431-9214-57788925C9BBQ35757916-AA858561-724F-4607-B8B2-BD5D1D07EEBDQ35900352-68049E58-4C1D-43CF-97AC-B928D07063A3Q35900356-EBC05073-80AC-4BD2-ADF8-FBF179E8667CQ35950440-AA70A26A-35CA-493B-8338-B2E619B6AD4EQ36017799-E83EDF66-46B8-4A86-83B9-DC94356050A1Q36044670-036E8F75-0A45-4B51-9513-62F59D14993BQ36483502-B1FEB334-7C31-4D8F-ABBD-D3F76E469BB6Q36727615-CC43BA86-7F9B-46EA-BE98-E212F664BA82
P2860
The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF
description
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1999
@ast
im Juli 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1999/07/15)
@sk
vědecký článek publikovaný v roce 1999
@cs
wetenschappelijk artikel (gepubliceerd op 1999/07/15)
@nl
наукова стаття, опублікована в липні 1999
@uk
научни чланак (објављен 1999/07/15)
@sr
name
The transcription factor MEF2C ...... ion of angiopoietin 1 and VEGF
@ast
The transcription factor MEF2C ...... ion of angiopoietin 1 and VEGF
@en
The transcription factor MEF2C ...... ion of angiopoietin 1 and VEGF
@nl
type
label
The transcription factor MEF2C ...... ion of angiopoietin 1 and VEGF
@ast
The transcription factor MEF2C ...... ion of angiopoietin 1 and VEGF
@en
The transcription factor MEF2C ...... ion of angiopoietin 1 and VEGF
@nl
prefLabel
The transcription factor MEF2C ...... ion of angiopoietin 1 and VEGF
@ast
The transcription factor MEF2C ...... ion of angiopoietin 1 and VEGF
@en
The transcription factor MEF2C ...... ion of angiopoietin 1 and VEGF
@nl
P2093
P3181
P356
P1476
The transcription factor MEF2C ...... ion of angiopoietin 1 and VEGF
@en
P2093
P304
P3181
P356
10.1006/DBIO.1999.9307
P407
P577
1999-07-15T00:00:00Z